The diagnostic and prognostic role of biomarkers in chronic rhinosinusitis

JJ Seah, M Thong, DY Wang - Diagnostics, 2023 - mdpi.com
Chronic rhinosinusitis (CRS) refers to an inflammatory disease of the sinonasal mucosa,
with a significant economic burden and impact on quality of life. The diagnosis of CRS is …

Targeting Epithelium Dysfunction and Impaired Nasal Biofilms to Treat Immunological, Functional, and Structural Abnormalities of Chronic Rhinosinusitis

K Petalas, J Goudakos, GN Konstantinou - International Journal of …, 2023 - mdpi.com
Chronic rhinosinusitis (CRS) with (CRSwNP) or without (CRSsNP) nasal polyps is a
prevalent and heterogeneous disorder existing as a spectrum of clinical conditions with …

Manifesto on united airways diseases (UAD): an Interasma (global asthma association–GAA) document

A Tiotiu, P Novakova, I Baiardini, A Bikov… - Journal of …, 2022 - Taylor & Francis
Objective: The large amount of evidence and the renewed interest in upper and lower
airways involvement in infectious and inflammatory diseases has led Interasma (Global …

Management paradigms for chronic rhinosinusitis in individuals with asthma: An evidence‐based review with recommendations

AS Gill, JA Alt, KY Detwiller, NR Rowan… - … Forum of Allergy & …, 2023 - Wiley Online Library
Background Despite the significant morbidity associated with chronic rhinosinusitis (CRS) in
individuals with asthma (CRSwA), there is a paucity of codified, evidence‐based …

Systemic corticosteroids in treatment of chronic rhinosinusitis—A systematic review

S Tamene, K Dalhoff, P Schwarz, V Backer… - European Clinical …, 2023 - Taylor & Francis
Purpose When first-line chronic rhinosinusitis (CRS) treatment fails, patients can either be
treated with oral or injected systemic corticosteroids. Although the EPOS and international …

Clinical and biological markers in disease and biologics to treat chronic rhinosinusitis

CL Guo, CS Wang, Z Liu - Current Opinion in Allergy and Clinical …, 2022 - journals.lww.com
Clinical and biological markers in disease and biologics to... : Current Opinion in Allergy and
Clinical Immunology Clinical and biological markers in disease and biologics to treat chronic …

Predictive Values of Serum IL‐33 and sST2 in Endotypes and Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps

Y Zhang, K Zhu, J Chen, C Xia, C Yu… - Mediators of …, 2022 - Wiley Online Library
Background. Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common inflammatory
disease with high heterogeneity and postoperative recidivation. The IL‐33/ST2 axis is …

[HTML][HTML] EoE behaves as a unique Th2 disease: a narrative review

SS Rabinowitz, L Yu, P Geraghty - Translational Gastroenterology …, 2023 - ncbi.nlm.nih.gov
Methods The following report consist of four related narrative reviews which combine
comprehensive PubMed and Google searches. Two reviews were performed to identify and …

Biologics in Chronic Rhinosinusitis: Current and Emerging

JT Boyd, AR Khanwalkar - Immunology and Allergy …, 2024 - immunology.theclinics.com
Chronic rhinosinusitis (CRS) represents an inflammatory state of the sinonasal
passageways with persistent associated symptoms. Clinically, CRS in adults is defined as …

[PDF][PDF] Outcome measures for chronic rhinosinusitis with nasal polyps

AR Sedaghat, RG Campbell, RG Douglas… - …, 2024 - researchgate.net
Background: With the recent proliferation of novel therapeutics for chronic rhinosinusitis with
nasal polyps (CRSwNP), there is an immediate need for comprehensive means to assess …